| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/21/1992 | US5082967 Novel fatty acid analog enzyme substrates |
| 01/21/1992 | US5082931 Type II bacterial Fc receptors |
| 01/21/1992 | US5082927 Genetic engineering, immunology |
| 01/21/1992 | US5082926 Polypeptide with type iv collagen cell adhesion, spreading and motility activity |
| 01/21/1992 | US5082828 Larvicides |
| 01/21/1992 | US5082783 Genetic engineering, biosynthesis |
| 01/21/1992 | US5082779 Method of directing transgenic expression in animals using a prolactin promoter |
| 01/21/1992 | US5082776 Method of producing an adult t cell leukemia virus fused antigen polypeptide |
| 01/21/1992 | US5082774 Genetic engineering |
| 01/21/1992 | US5082773 Biosynthesis |
| 01/21/1992 | US5082670 Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
| 01/21/1992 | US5082659 Methods and compositions employing interferon-gamma |
| 01/21/1992 | US5082657 Leukoregulin, an antitumor lymphokine, and its therapeutic uses |
| 01/21/1992 | CA1294738C Chemical derivatives of ghl-cu |
| 01/21/1992 | CA1294736C Renin inhibitors containing 5-amino-2,5-disubstituted- 4-hydroxypentanoic acid residues |
| 01/21/1992 | CA1294570C Monoclonal antibodies specifically directed against prosomal proteins |
| 01/20/1992 | WO1992001715A1 Soluble cell-surface dimeric proteins |
| 01/20/1992 | WO1992001472A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | WO1992001464A1 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs |
| 01/20/1992 | CA2087545A1 Soluble cell-surface dimeric proteins |
| 01/20/1992 | CA2087541A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | CA2087169A1 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs |
| 01/20/1992 | CA2047317A1 Amphiphilic peptide compositions and analogues thereof |
| 01/20/1992 | CA2047078A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047073A1 Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
| 01/20/1992 | CA2047043A1 Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties |
| 01/20/1992 | CA2047042A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047033A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047031A1 Peptide-polysaccharide-protein conjugate vaccines |
| 01/20/1992 | CA2047030A1 Class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties |
| 01/20/1992 | CA2045231A1 Cell membrane glycoprotein correlated with resistance to platinum-containing antineoplastic agents |
| 01/20/1992 | CA2021591A1 Synthetic chondroitin sulfate proteoglycan and process for producing the same |
| 01/19/1992 | WO1992001467A1 Method for treating viral infections using oxidized lipoproteins |
| 01/19/1992 | CA2086921A1 Method for treating viral infections using oxidized lipoproteins |
| 01/19/1992 | CA2047313A1 Polypeptides |
| 01/19/1992 | CA2047028A1 Gene encoding candida albicans plasma membrane h+atpase |
| 01/19/1992 | CA2046754A1 Dna coding for a human vasoconstrictive peptide and use thereof |
| 01/19/1992 | CA2045714A1 Use of a centrally acting acth analog in the manufacture of a medicament |
| 01/18/1992 | WO1992001781A1 Antibody-mediated cofactor-driven reactions |
| 01/18/1992 | CA2086755A1 Antibody-mediated cofactor-driven reactions |
| 01/18/1992 | CA2035836A1 Reduction of oxyradical damage in biomedical applications |
| 01/17/1992 | WO1992001797A1 IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA) |
| 01/17/1992 | CA2084189A1 Immunoglobulin production by trichoderma |
| 01/17/1992 | CA2047091A1 Method for producing gene protein products |
| 01/17/1992 | CA2045842A1 Dna capable of site-specific integration into mycobacteria |
| 01/16/1992 | DE4021917A1 O-glycosylated alpha-interferon, used as medicament - isolated following secretion into conditioned medium of mammalian cells contg. a suitable expression plasmid |
| 01/15/1992 | EP0466505A2 Artificial antibody |
| 01/15/1992 | EP0466498A1 Physiologically active peptides having immunoregulatory activities |
| 01/15/1992 | EP0466440A2 Anti-metastatic factor |
| 01/15/1992 | EP0466251A1 Elfamycin-resistant mutants |
| 01/15/1992 | EP0466222A1 Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using |
| 01/15/1992 | EP0466204A1 Novel polypeptides, DNAs that code for the same, and method of preparing said polypeptides and DNAs |
| 01/15/1992 | EP0466199A1 Polypeptide fragments of factor VIIIc, corresponding probes and DNA sequences and DNA constructs |
| 01/15/1992 | EP0466175A1 Porcine CNP gene and precursor protein |
| 01/15/1992 | EP0466174A1 Novel physiologically active porcine peptide (CNP-53) |
| 01/15/1992 | EP0466083A2 Method for site-directed mutagenesis |
| 01/15/1992 | EP0465979A1 Anti HTLV-III (strain MN) monoclonal antibody |
| 01/15/1992 | EP0465895A1 WS7622A di- sulfate, process for preparation thereof and use thereof |
| 01/15/1992 | EP0465652A1 Antibody against heavy chain of smooth muscle myosin |
| 01/15/1992 | EP0465633A1 C4 binding protein fusion proteins |
| 01/15/1992 | EP0465602A1 METHOD FOR DETECTION AND/OR IDENTIFICATION OF $i(LYSSAVIRUS) INFECTIONS, CLONING AND EXPRESSION OF GENES CODING FOR PEPTIDES AND/OR FRAGMENTS OF PEPTIDES OF MOKOLA $i(LYSSAVIRUS), VACCINE AGAINST THE MOKOLA VIRUS AND/OR THE FAMILY OF $i(LYSSAVIRUSES) AS WELL AS METHOD FOR OBTAINING SAID VACCINE VIA |
| 01/15/1992 | EP0465539A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 01/15/1992 | EP0465529A1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 01/15/1992 | EP0465495A1 Ribozome inactivating proteins and derivatives thereof |
| 01/15/1992 | EP0462205A4 Leukocyte adhesion receptors |
| 01/15/1992 | EP0367795A4 Affinity separating using immobilized flocculating reagents |
| 01/15/1992 | EP0235162B1 Cdna and gene for human angiogenin (angiogenesis factor) and methods of expression |
| 01/15/1992 | CN1057862A Muteins of granulocyte colony stimulating factor |
| 01/15/1992 | CN1057861A Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide |
| 01/15/1992 | CN1057785A Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof |
| 01/15/1992 | CN1057784A Growth hormone releasing factor analogs |
| 01/14/1992 | WO1992001053A1 Plasmid containing dna which codes for the amino acid sequence of tcf-ii, transformed cell, and production of physiologically active substance by using the same |
| 01/14/1992 | WO1992001039A1 Promotion of maturation of hematopoietic progenitor cells |
| 01/14/1992 | WO1992000998A1 Growth hormone crystals and a process for production of these gh-crystals |
| 01/14/1992 | WO1992000753A1 PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9 |
| 01/14/1992 | US5081230 Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein |
| 01/14/1992 | US5081228 Interleukin-1 receptors |
| 01/14/1992 | US5081226 Synthetic peptides sharing sequence homology with the HIV envelope protein |
| 01/14/1992 | US5081225 Gram-positive and gram-negative antibacterial compounds from the microorganism, janthinobacterium lividum |
| 01/14/1992 | US5081034 Genetic engineering |
| 01/14/1992 | US5081031 Synthetic polypeptide with type iv collagen activity |
| 01/14/1992 | US5081029 Acitivation of T lymphocytes |
| 01/14/1992 | US5081028 Preparation of transformed hosts which express binding factor related polypeptides |
| 01/14/1992 | US5081022 Vector for the cloning and expression of γ-interferon, transformed bacteria and process for the preparation of γ-interferon |
| 01/14/1992 | US5081021 DNA encoding HTNF variants exhibiting enhanced activity |
| 01/14/1992 | US5081020 DNA sequences, genetic engineering and polypeptides for bovine growth hormones |
| 01/14/1992 | US5081019 DNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptides |
| 01/14/1992 | US5081010 Alcoholamine, ethylene oxide alkylphenol compound; medical diagnosis |
| 01/14/1992 | US5080898 Enzymatically active toxin coupled to a cell-specific ligand |
| 01/14/1992 | US5080897 Novel bacillus thuringiensis strains, and related insecticidal compositions |
| 01/14/1992 | CA2087190A1 Parathyroid hormone analogues modified at positions |
| 01/14/1992 | CA2087170A1 Promotion of maturation of hematopoietic progenitor cells |
| 01/14/1992 | CA1294233C Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody |
| 01/14/1992 | CA1294232C Process for preparing glucagon or derivatives or fragments thereof in yeast |
| 01/14/1992 | CA1294231C Method of producing peptides |
| 01/13/1992 | WO1992001051A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/13/1992 | CA2087005A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/12/1992 | WO1992000985A1 Streptomyces vectors for production of heterologous proteins |
| 01/12/1992 | WO1992000755A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |
| 01/12/1992 | CA2087018A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |